Exail Technologies S.A. (EXA)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 125.30 |
|---|---|
| 52-week range | 70.70 – 159.20 |
| Return, 1 month / 3 months | +0.2% / +1.0% |
| Return, 1 year / 3 years | +51.1% / +673.5% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 57.5% |
| Worst drawdown (1 year) | -37.4% |
| Average daily value traded | 4.53M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Exail Technologies is a French industrial company that builds high-technology equipment for demanding environments, chiefly at sea and in the air. Its products include autonomous underwater vehicles, unmanned surface and aerial drones, navigation and positioning systems, and robotics used in offshore energy, defence and scientific research. Customers are mainly navies, maritime survey and energy operators, and aerospace and defence contractors. The company is based in France and supplies clients in Europe and other markets around the world.
The shares are listed on the Euronext Paris in France under the code EXA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Exail Technologies S.A. (EXA) trades on the Euronext Paris in France. It last closed at EUR 125.30 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 112 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 51.1% and over the last three months it rose 1.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 2.8% | ||
| From 52-week high | -15.8% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 1.0% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 50.8% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 57.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.4% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 4.53M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.2% |
|---|---|
| 1 month | +0.2% |
| 3 months | +1.0% |
| 6 months | +0.0% |
| 1 year | +51.1% |
| 3 years | +673.5% |
| 5 years | +988.0% |
Signals
| 50-day / 200-day average | 124.67 / 121.93 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Jun 2021 | EUR 0.2378 |
| 1 Jul 2020 | EUR 0.2378 |
| 4 Jul 2019 | EUR 0.2378 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.